New catheter lock could slash infection risk in young cancer patients

NCT ID NCT05781295

Recruiting now Prevention Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special solution (taurolidine) placed inside the catheter can prevent infections better than the standard saltwater solution. About 148 children with cancer who need a central catheter will take part. The goal is to see if the taurolidine lock reduces the number of catheter-related bloodstream infections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDREN MEDICAL DEVICE ONCOLOGY PRIMARY PREVENTION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Armand Trousseau
RECRUITING

Paris, 75012, France

Contact Email: •••••@•••••

Contact
Gustave Roussy
RECRUITING

Villejuif, 94805, France

Contact Email: •••••@•••••

Contact
Institut Curie
RECRUITING

Paris, 75005, France

Contact Email: •••••@•••••

Contact
Robert Debre
RECRUITING

Paris, 75935, France

Contact Email: •••••@•••••

Contact
Saint Louis
RECRUITING

Paris, 75010, France

Contact Email: •••••@•••••

Contact